Final ID: Sa2040
Yoshida Yilin, Qi Qibin, Cheng Susan, Kaplan Robert, Rodriguez Carlos, Shah Amil, Yu Bing, Nguyen Ngoc Quynh, Moon Eun Hye, Casey Rebholz, Skali Hicham, Arthur Victoria, Echouffo Justin, Ballantyne Christie, Selvin Elizabeth
Aficamten is safe and effective in oHCM with comorbidities obesity, hypertension, and diabetes: a SEQUOIA-HCM sub-studyLee Matthew, Malik Fady, Kupfer Stuart, Wohltman Amy, Coats Caroline, Abraham Theodore, Claggett Brian, Maron Martin, Miao Zi, Meder Benjamin, Olivotto Iacopo, Heitner Stephen, Jacoby Daniel